Pricing Log in Create free account

Bicara Therapeutics Inc. (BCAX) vs Valneva SE Sponsored ADR (VALN)

Bicara Therapeutics Inc. and Valneva SE Sponsored ADR are both Biotechnology companies. Bicara Therapeutics Inc. and Valneva SE Sponsored ADR are of similar size ($542.0M and $536.5M). Bicara Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Valneva SE Sponsored ADR trades at 59.3×. Bicara Therapeutics Inc. has the higher net margin (0.00% vs −12.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Valneva SE Sponsored ADR leads on 6 and Bicara Therapeutics Inc. on 5.

Valuation

Metric BCAX VALN Biotechnology median
P/E n/m 59.26 10.60
P/S n/m 3.02 9.40
P/B 1.25 5.26 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 42.64 0.66
EV/Sales n/m 3.47 9.02
Earnings yield (36.00%) 1.69% (32.88%)
Free cash flow yield (23.13%) (11.87%) (23.13%)

Profitability

Metric BCAX VALN Biotechnology median
Gross margin — 38.28% 68.51%
Operating margin 0.00% 13.56% 0.00%
Net margin 0.00% (12.01%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (41.01%) 0.00% (51.96%)
Return on assets (38.38%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BCAX VALN Biotechnology median
Revenue growth (TTM) — (53.16%) 6.76%
EPS growth (last fiscal year) 37.78% (805.88%) 29.88%
Revenue growth, 5-year CAGR — 9.41% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BCAX VALN Biotechnology median
Debt to equity 0.00 2.27 0.00
Current ratio 11.59 2.16 4.97
Net debt to EBITDA 2.67 (1.15) 1.01

Dividend

Metric BCAX VALN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BCAX VALN Biotechnology median
Market cap 541.96m 536.53m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack